Clinical trial
Effects of Antidepressants on Sexual Functioning
NCT00051259 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00051259 |
|---|---|
| Title | Effects of Antidepressants on Sexual Functioning |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Effects on Sexual Functioning of Extended-Release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients With Moderate to Severe Major Depression Over an Eight-Week Treatment Period |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder (MDD) |
| Intervention type | Drug |
| Interventions | Extended-Release Bupropion Hydrochloride |
| Enrollment | 420 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Jan 8, 2003 |
| Last update posted | Oct 4, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: